We have extensive project experience in pharmaceutical and biotechnology strategies. Our know-how spans all phases of the product lifecycle, from early stage opportunity assessment to comprehensive implementation planning and support to lifecycle management.
We also assist our clients in defining strategies at the portfolio, franchise and enterprise level. This includes therapeutic area strategies, licensing and acquisitions, and corporate growth strategies.
We have worked in all major therapeutic areas in both developed and emerging markets. We work with organizations of all sizes, from the top 10 pharmaceutical companies to early start-ups.
Pipeline Discovery & Development
Lead Indication Prioritisation
- Broad/indication assessment: MOA, CT, data mapping
- Trend analysis and opportunity assessment
- Indication prioritisation and initial LCM planning
- Growth Bottleneck and Market Sizing
Early Indication Selection
- Lead indication gap analysis
- Integrated evidence strategy planning
- Launch strategy, competitive readiness
Brand Launch & Lifecycle Strategy
Launch Excellence
- Cross-functional alignment
- Stakeholder engagement
- Market-specific strategies
Mid-Late Lifecyle (LLC) Optimisation
- Strategic indication sequencing
- LE/reformulation/market expansion
- Explore product-plus-service offering
LOE Preparation
- LLC situational analysis
- Market archetyping and mapping
- Local LLC tactical planning & execution
Established Brand Optimisation
- Mapping of post-LOE opportunities
- Growth market strategy support
- EB portfolio management
Therapeutic Area and Corporate Strategy
Portfolio Strategy
- Therapeutic Needs Assessment
- Portfolio Management
- Pipeline Prioritization
- Franchise Growth Strategy & Business Case
- Patient Services Strategy
Corporate Strategy
- Geographic Market Entry Strategy
- Therapeutic Area Entry Strategy
- Acquisition Target Identification & Screening
- Commercial Due Diligence
- Scientific, IP and Regulatory Due Diligence